logo

For the Inventor, By the Inventor

Carrollton, TX, United States of America

Gradalis, Inc.


USPTO Granted Patents = 23

% Expired Patents = 34.8


Trademarks = 3

Forward Citations = 105

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Donald Rao (16 out of 21 patents)

silverMedal John J Nemunaitis (13 out of 17 patents)

bronzeMedal Neil Senzer (11 out of 11 patents)

4.  Phillip B Maples (10 out of 15 patents)

5.  Nancy Smyth Templeton (6 out of 7 patents)

6.  David M Shanahan (5 out of 10 patents)

7.  F Charles Brunicardi (1 out of 4 patents)

8.  Ernest Bognar (1 out of 1 patent)

9.  Zhaohui Wang (0 patent)


23 patents:

1. 11400170 - Methods for treating cancers (2022-08-02),
2. 10253331 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2019-04-09),
3. 9914977 - Individualized cancer therapy (2018-03-13),
4. 9790518 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2017-10-17),
5. 9695422 - Furin-knockdown bi-functional RNA (2017-07-04),
6. 9528991 - Individualized cancer therapy (2016-12-27),
7. 9382589 - Individualized cancer therapy (2016-07-05),
8. 9157084 - Furin-knockdown bi-functional RNA (2015-10-13),
9. 9132146 - Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine (2015-09-15),
10. 8969068 - Processes for the preparation of highly pure plasmid compositions by enzymatic digestion of colanic acid (2015-03-03),
11. 8916530 - Individualized cancer therapy (2014-12-23),
12. 8906874 - Bi-functional shRNA targeting Stathmin 1 and uses thereof (2014-12-09),
13. 8808983 - shRNA molecules and methods of use thereof (2014-08-19),
14. 8758998 - Construction of bifunctional short hairpin RNA (2014-06-24),
15. 8735119 - Polypeptides having colanic acid-degrading activity (2014-05-27),
Company Overview
Gradalis, Inc. is a biotechnology company based in Carrollton, Texas, specializing in the development of innovative cancer immunotherapies. The organization focuses on harnessing the body's immune system to target and eliminate cancer cells, with a commitment to advancing personalized medicine. Gradalis aims to improve treatment outcomes for patients through its proprietary technologies and research initiatives, contributing to the evolving landscape of cancer treatment and patient care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

Gradalis, Inc. USPTO Patent Assignee Logo
23 Patents

#11 in Carrollton, TX

#850 in Texas

#14,428 in US

#27,685 in the World

Carrollton, TX (US)
Carrollton, TX, United States of America

Gradalis, Inc.

Forward Citations = 105

8 inventors:

goldMedal Donald Rao (16 out of 21 patents)

silverMedal John J Nemunaitis (13 out of 17 patents)

bronzeMedal Neil Senzer (11 out of 11 patents)

4.  Phillip B Maples (10 out of 15 patents)

5.  Nancy Smyth Templeton (6 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Gradalis, Inc.. Retrieved from https://idiyas.com/company/gradalis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…